How Obesity Influences Psoriatic Arthritis Risk and Outcomes
Philip Mease, MD, MACR
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
A Visual Guide to Cutaneous Dermatomyositis
Avery H. LaChance, MD, MPH, FAAD
Understanding Difficult-to-Treat Axial Spondyloarthritis in Real-World Practice
The Next Era of Psoriatic Arthritis Management
Laura Coates, MBChB, MRCP, PhD
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Unpacking the Complexity of Psoriatic Arthritis
Lawrence H. Brent
Modern Approaches to Psoriatic Arthritis Management
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
Ryan Quigley
Molecular Signals and Early Detection in Psoriatic Arthritis
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Steve Jackson, PharmD
Marc Scherlinger, MD, PhD
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Luigi Adamo, MD, PhD
Andrea Fava, MD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Gary S. Firestein, MD
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.